Alphyn Biologics
Pharmaceuticals, 3724a Thomas Pt Rd, Cincinatti/Annapolis, Maryland, 21403, United States, 1-10 Employees
Phone Number: +14*********
Who is ALPHYN BIOLOGICS
Alphyn Biologics is a clinical-stage dermatology company developing first-in-class multi-target therapeutics for severe and prevalent skin diseases based on its AB-101 platform. Its lead ...
Read More
-
Headquarters: 3724a Thomas Pt Rd, Cincinatti/Annapolis, Maryland, 21403, United States
-
Date Founded: 2019
-
Employees: 1-10
-
Revenue: Under $1 Million
-
Active Tech Stack: See technologies
-
CEO:
Neal Koller
Email
Phone
Industry: Pharmaceuticals
SIC Code: 2834
|
NAICS Code: 325412 |
Show More
Does something look wrong? Fix it. | View contact records from ALPHYN BIOLOGICS
Alphyn Biologics Org Chart and Mapping
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Alphyn Biologics
Answer: Alphyn Biologics's headquarters are located at 3724a Thomas Pt Rd, Cincinatti/Annapolis, Maryland, 21403, United States
Answer: Alphyn Biologics's phone number is +14*********
Answer: Alphyn Biologics's official website is https://alphynbiologics.com
Answer: Alphyn Biologics's revenue is Under $1 Million
Answer: Alphyn Biologics's SIC: 2834
Answer: Alphyn Biologics's NAICS: 325412
Answer: Alphyn Biologics has 1-10 employees
Answer: Alphyn Biologics is in Pharmaceuticals
Answer: Alphyn Biologics contact info: Phone number: +14********* Website: https://alphynbiologics.com
Answer: Alphyn Biologics is a clinical-stage dermatology company developing first-in-class multi-target therapeutics for severe and prevalent skin diseases based on its AB-101 platform. Its lead product candidate, AB-101a, is a topical treatment for atopic dermatitis (AD), the most common form of eczema, and has completed a Phase 2a clinical trial. AB-101a has demonstrated a strong safety profile and is in development to uniquely target AD's bacterial and immune system components, making it ideal for treating infected and non-infected AD. Alphyn's AB-101 platform has multiple bioactive compounds and, therefore, multiple mechanisms of action to support a robust pipeline of dermatologic therapeutics with potential safety, efficacy, and regulatory marketing authorization advantages. Alphyn is based in Annapolis, Maryland, and Cincinnati, Ohio, and has a wholly-owned subsidiary in Australia. We became operational in 2020 and have raised approximately $6.7 million.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month